Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: J Neurosci Res. 2011 Mar 3;89(6):874–882. doi: 10.1002/jnr.22604

Figure 3.

Figure 3

Baseline cAMP in CHO cells. (A) When assayed simultaneously, Rhes did not affect baseline cAMP values, whereas AGS1/Dexras1 did (*p<0.05 by One-Factor ANOVA with post-hoc Bonferroni tests, n = 5). (B) The D1 receptor antagonist SCH23390 attenuated baseline cAMP accumulation in a concentration-responsive fashion. Data were analyzed by One-Factor ANOVA followed by Bonferroni post-tests. *p<0.05, **p<0.01, n = 4.